Orladeyo Patent Litigation Status in 2025
As of 2025, BioCryst Pharmaceuticals faces ongoing patent challenges for its hereditary angioedema (HAE) treatment, Orladeyo (berotralstat) [1]. These legal battles are critical as they determine the timeline for potential generic competition and the drug's market exclusivity.
Who is Challenging Orladeyo Patents?
Multiple entities are involved in challenging BioCryst's patents for Orladeyo. These challenges are often initiated by generic drug manufacturers seeking to bring their versions of the drug to market sooner [1].
What Patents are Being Challenged?
The patent landscape for Orladeyo is complex, with challenges targeting various patents that cover the drug's composition, manufacturing processes, and methods of use [1]. These patents are key to BioCryst's ability to maintain market exclusivity. Information on specific patent numbers and their expiration dates can be found on DrugPatentWatch.com [2].
When Does Orladeyo Patent Exclusivity End?
The exact end date for Orladeyo's patent exclusivity is subject to the outcomes of the ongoing litigation [1]. While BioCryst holds patents that extend into the future, the challenges could potentially shorten this period, allowing for earlier generic entry. DrugPatentWatch.com provides detailed timelines for patent expirations and potential market entry dates for generics [2].
What Happens if Patents are Invalidated?
If patents protecting Orladeyo are successfully challenged and invalidated, it could pave the way for generic versions of berotralstat to enter the market. This would likely lead to increased price competition and a reduction in BioCryst's market share for the drug [1].
How Do Patent Lawsuits Affect Orladeyo's Price?
Patent litigation directly impacts the pricing of prescription drugs. As long as a drug is protected by strong patents and market exclusivity, its manufacturer can command higher prices. A successful challenge to these patents and the subsequent introduction of generics typically leads to significant price reductions [1].
What is the Commercial Impact of Generic Competition?
The introduction of generic drugs following patent expirations can drastically alter the market dynamics for a branded medication. Generic competitors usually offer their products at a substantially lower cost, which can erode the market share and revenue of the originator drug [1].
Where Can I Find More Information on Drug Patents?
Detailed information regarding drug patents, including expiration dates, legal challenges, and potential generic entry timelines, is available from resources like DrugPatentWatch.com [2].
Sources
1. BioCryst Pharmaceuticals
2. DrugPatentWatch.com